4.7 Article

A one-pot CRISPR-Cas12a-based toolbox enables determination of terminal deoxynucleotidyl transferase activity for acute leukemia screening

期刊

ANALYTICA CHIMICA ACTA
卷 1254, 期 -, 页码 -

出版社

ELSEVIER
DOI: 10.1016/j.aca.2023.341115

关键词

CRISPR; Cas12a; Fluorescence; Collateral cleavage; crRNA; TdT activity

向作者/读者索取更多资源

An isothermal, one-pot toolbox based on CRISPR-Cas12a collateral cleavage capability (OPT-Cas) is proposed for highly sensitive and selective determination of terminal deoxynucleotidyl transferase (TdT) activity. The toolbox allows simple but high-sensitive quantification of TdT activity with low detection limits and achieves extraordinary selectivity. Furthermore, it has been successfully used for the detection of TdT in complex matrices and accurate determination of TdT activity in acute lymphoblastic leukemia cells.
An isothermal, one-pot toolbox (called OPT-Cas) based on CRISPR-Cas12a collateral cleavage capability is proposed for highly sensitive and selective determination of terminal deoxynucleotidyl transferase (TdT) activity. Oligonucleotide primers with 3 '-hydroxyl (OH) terminal were randomly introduced for TdT-induced elongation. In the presence of TdT, dTTP nucleotides polymerized at the 3 ' terminals of the primers to generate abundant polyT-tails, which function as triggers for the synchronous activation of Cas12a proteins. Finally, the activated Cas12a trans-cleaved FAM and BHQ1 dual-labeled single-stranded DNA (ssDNA-FQ) reporters, producing significantly amplified fluorescence signals. This one-pot assay, that is primer, crRNA, Cas12a protein and ssDNA-FQ reporter are all in one tube, allows simple but high-sensitive quantification of TdT activity with a low detection limit of 6.16 x 10-5 U mu L-1 in the concentration scope from 1 x 10-4 U mu L-1 to 1 x 10-1 U mu L-1, and achieves extraordinary selectivity with other interfering proteins. Furthermore, the OPT-Cas was successfully used to detect TdT in complex matrices and accurate determination of TdT activity in acute lymphoblastic leukemia cells, which might be a reliable technique platform for the diagnosis of TdT-related diseases and biomedical research applications.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据